Vladimir Zah, PhD

Chief Science Officer
ZRx Outcomes Research inc.
Mississauga, Ontario, Canada

Disclosure information not submitted.

Presentation(s):

• Healthcare Cost and Resource Use in Chronic Low Back Pain Patients Treated with Belbuca® and Buprenorphine Transdermal Patches: A Retrospective US Commercial Claims Analysis

  POSTER ABSTRACT

• Safety and Tolerability of Schedule III Buprenorphine and Oral Schedule II Opioid Treatment in Chronic Low Back Pain Patients: A Retrospective US Commercial Claims Analysis

  POSTER ABSTRACT

• Treatment Characteristics of Chronic Low Back Pain Patients Treated with Belbuca® and Buprenorphine Transdermal Patches: A Retrospective US Commercial Claims Analysis

  POSTER ABSTRACT